MACRODANTIN

50 Milligram Capsules Hard

Mercury Pharmaceuticals LtdPA0899/012/001

SPC: Preclinical safety data

15 May 2015 - 22 Jan 201622 Jan 2016 - Present

Non-clinical data reveal no special hazards for humans based on conventional studies of safety pharmacology, repeated dose toxicity,genotoxicity, carcinogenic potential, and toxicity to reproduction.

Non-clinical data reveal no special hazards for humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity, carcinogenic potential, and toxicity to reproduction.

« Back

Latest Changes to Medicine Info & SPC


Please note changes to the medicine information and summary of product characteristics are only available from the 19/05/2015 onwards. Changes made before this date aren't available online.